×
Eli Lilly Inventory 2012-2026 | LLY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Eli Lilly inventory for the quarter ending March 31, 2026 was
$13.744B
, a
81.1% increase
year-over-year.
Eli Lilly inventory for 2025 was
$13.744B
, a
81.1% increase
from 2024.
Eli Lilly inventory for 2024 was
$7.589B
, a
31.46% increase
from 2023.
Eli Lilly inventory for 2023 was
$5.773B
, a
33.95% increase
from 2022.
View More
Eli Lilly Inventory 2012-2026 | LLY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Eli Lilly inventory for 2025 was
$13.744B
, a
81.1% increase
from 2024.
Eli Lilly inventory for 2024 was
$7.589B
, a
31.46% increase
from 2023.
Eli Lilly inventory for 2023 was
$5.773B
, a
33.95% increase
from 2022.
Related Stocks
Company Name
Market
Cap
Johnson & Johnson (JNJ)
$574.4B
AbbVie (ABBV)
$367.7B
Roche Holding AG (RHHBY)
$318.8B
Merck (MRK)
$299.9B
Novartis AG (NVS)
$294B
Novo Nordisk (NVO)
$167.5B
Pfizer (PFE)
$153.1B
Sanofi (SNY)
$114B
Bayer (BAYRY)
$46.2B
Innoviva (INVA)
$1.8B